Sponsor or institution
Clinical trials and research at Jubilant Therapeutics Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Jubilant Therapeutics Inc. that are recruiting, at sites in 2 countries (most in Australia (1), India (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
First‑in‑human test of JBI-778 in lung cancer, glioma, and salivary gland cancers
This early-phase study tests whether the oral drug JBI-778 is safe and shows activity in adults with EGFR-mutated NSCLC, IDH-mutant glioma, or adenoid cystic carcinoma that has spread or is advanced.
-
Orally administered JBI-802 in certain blood cancers with high platelets
This study tests whether taking JBI-802 by mouth can be safe and helpful for adults with essential thrombocythemia or related blood cancers that involve high platelet counts.
Quick answers
How many clinical trials run by Jubilant Therapeutics Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.